Company intelligence

Parabilis Medicines

BiotechActive
We're still building this profile — here is what Pulse has covered.

Investors

ARCH Venture PartnersNextech Invest

Latest Pulse

  1. Biotech's IPO Window Reopens With Record DebutsA run of 2026 biotech IPOs, led by Parabilis Medicines and Kailera Therapeutics, has broken records once held by Moderna, signaling the biotech public-market window has genuinely reopened after years of caution.→

Coverage Timeline

newest first
  1. IPOBiotech's IPO Window Reopens With Record Debuts→

All Coverage

IPO

Biotech's IPO Window Reopens With Record Debuts

Related Companies

Same sector
Attovia TherapeuticsApnimedBraveheart BioLatigo BiotherapeuticsScribe Therapeutics